Clinical Trial Update: A Phase 1b/2 Study of the Safety and Efficacy of the Monoclonal Antibody OM-RCA-01 in Patients With Metastatic Tumors Expressing Fibroblast Growth Factor Receptor 1 [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1b/2 clinical trial evaluating the monoclonal antibody OM-RCA-01 in metastatic tumors expressing FGFR1 is currently recruiting across several cancer typ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer Metastatic
• Head and Neck Cancer Metastatic
• Non-small Cell Lung Cancer Metastatic
• Prostate Cancer Metastatic
• Renal Cell Carcinoma Metastatic

Drugs mentioned

• OM-RCA-01

Snippet

Sponsor: Kidney Cancer Research Bureau | Conditions: Renal Cell Carcinoma Metastatic, Prostate Cancer Metastatic | Phase 1, Phase 2 | Status: RECRUITING